View in EDS

Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapy.

Saved in:
Bibliographic Details
Title: Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapy.
Authors: Burkhardt UE; Accelerating Cancer Immunotherapy Research, Concord, MA, USA. ute.burkhardt@acir.org., Fritsch EF; Accelerating Cancer Immunotherapy Research, Concord, MA, USA. ed.fritsch@acir.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ed.fritsch@acir.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. ed.fritsch@acir.org.
Source: Genes and immunity [Genes Immun] 2023 Dec; Vol. 24 (6), pp. 292-294. Date of Electronic Publication: 2023 Dec 11.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 100953417 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5470 (Electronic) Linking ISSN: 14664879 NLM ISO Abbreviation: Genes Immun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38082155
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Burkhardt+UE%22">Burkhardt UE</searchLink>; Accelerating Cancer Immunotherapy Research, Concord, MA, USA. ute.burkhardt@acir.org.<br /><searchLink fieldCode="AU" term="%22Fritsch+EF%22">Fritsch EF</searchLink>; Accelerating Cancer Immunotherapy Research, Concord, MA, USA. ed.fritsch@acir.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ed.fritsch@acir.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. ed.fritsch@acir.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100953417%22">Genes and immunity</searchLink> [Genes Immun] 2023 Dec; Vol. 24 (6), pp. 292-294. <i>Date of Electronic Publication: </i>2023 Dec 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100953417 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5470 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214664879%22">14664879 </searchLink><i>NLM ISO Abbreviation: </i>Genes Immun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38082155
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41435-023-00227-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 292
    Titles:
      – TitleFull: Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burkhardt UE
      – PersonEntity:
          Name:
            NameFull: Fritsch EF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5470
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Genes and immunity
              Type: main
ResultId 1